{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:14:59Z","timestamp":1785190499132,"version":"3.55.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1080\/13696998.2020.1813144","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T13:01:50Z","timestamp":1597928510000},"page":"1345-1355","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":30,"title":["Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance \u2013 the perspective of private and public payers"],"prefix":"10.1080","volume":"23","author":[{"given":"Nirmish R.","family":"Shah","sequence":"first","affiliation":[{"name":"Duke Adult Comprehensive Sickle Cell Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menaka","family":"Bhor","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick","family":"Latremouille-Viau","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Kumar Sharma","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pvt. Ltd, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Puckrein","sequence":"additional","affiliation":[{"name":"National Minority Quality Forum, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gagnon-Sanschagrin","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Khare","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pvt. Ltd, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Kumar Singh","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pvt. Ltd, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Serra","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikha\u00efl","family":"Davidson","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liou","family":"Xu","sequence":"additional","affiliation":[{"name":"National Minority Quality Forum, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Guerin","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.10"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.022"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-3-50"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61029-X"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23683"},{"key":"CIT0006","unstructured":"National Institute of Health \u2013 National Heart Lung and Blood Institute. Evidence-based management of sickle cell disease 2014; [cited 2019 November 4]. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/evidence-based-management-sickle-cell-disease."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107043250103"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20336"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2018.1549801"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10305"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25233"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnw074"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4860"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322001"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1088827"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3075"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715971"},{"key":"CIT0019","unstructured":"US Food and Drug Administration. Prescribing Information \u2013 ENDARI (L-glutamine) [cited 2020 Feb 26]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/208587s001lbl.pdf."},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903212"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770"},{"key":"CIT0022","unstructured":"US Food and Drug Administration. Prescribing Information \u2013 ADAKVEO\u00ae (crizanlizumab-tmca); [cited 2020 Feb 25]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761128s000lbl.pdf."},{"key":"CIT0023","unstructured":"Fingar KR, Owens PL, Reid LD, et\u00a0al. Characteristics of Inpatient Hospital Stays Involving Sickle Cell Disease, 2000\u20132016: Statistical Brief #251. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD). 2019."},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-019-1225-7"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20180"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-131721"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.09.2666"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214355"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-019-02412-5"},{"key":"CIT0030","unstructured":"Center for Disease Control and Prevention \u2013 National Center on Birth Defects and Developmental Disabilities. Sickle Cell Data Collection Program Report: Data to Action 2018; [cited 2018 Feb 27]. Available from: https:\/\/www.cdc.gov\/ncbddd\/hemoglobinopathies\/data-reports\/2018-summer\/documents\/sickle-cell-data-to-action-h.pdf."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199909000-00010"},{"issue":"1","key":"CIT0032","first-page":"44","volume":"112","author":"Woods K","year":"1997","journal-title":"Public Health Rep"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21515"},{"issue":"7","key":"CIT0034","first-page":"1109","volume":"98","author":"Epstein K","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-2016-002983"},{"issue":"195","key":"CIT0036","first-page":"1","author":"Hing E","year":"2015","journal-title":"NCHS Data Brief"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24459"},{"key":"CIT0038","unstructured":"The Henry J. Kaiser Family Foundation. Distribution of Medicaid spending by service. 2018 [cited 2020 Mar 27]. Available from: https:\/\/www.kff.org\/medicaid\/state-indicator\/distribution-of-medicaid-spending-by-service\/view\/print\/?currentTimeframe=0&print=true&hx0026;sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D."},{"key":"CIT0039","unstructured":"Medicare Payment Advisory Commission. Chapter 1: context for Medicare payment policy 2018 [cited 2020 Mar 27]. Available from: http:\/\/www.medpac.gov\/docs\/default-source\/reports\/mar20_medpac_ch1_sec.pdf?sfvrsn=0"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2020.1813144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T07:14:32Z","timestamp":1620544472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2020.1813144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,1]]}},"alternative-id":["10.1080\/13696998.2020.1813144"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2020.1813144","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}